美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA209081"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
59651-010-18 59651-010 HUMAN PRESCRIPTION DRUG Ranolazine Ranolazine TABLET, FILM COATED, EXTENDED RELEASE ORAL 20221223 N/A ANDA ANDA209081 Aurobindo Pharma Limited RANOLAZINE 1000 mg/1 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-010-18)
59651-010-60 59651-010 HUMAN PRESCRIPTION DRUG Ranolazine Ranolazine TABLET, FILM COATED, EXTENDED RELEASE ORAL 20221223 N/A ANDA ANDA209081 Aurobindo Pharma Limited RANOLAZINE 1000 mg/1 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-010-60)
59651-010-99 59651-010 HUMAN PRESCRIPTION DRUG Ranolazine Ranolazine TABLET, FILM COATED, EXTENDED RELEASE ORAL 20221223 N/A ANDA ANDA209081 Aurobindo Pharma Limited RANOLAZINE 1000 mg/1 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-010-99)
59651-009-99 59651-009 HUMAN PRESCRIPTION DRUG Ranolazine Ranolazine TABLET, FILM COATED, EXTENDED RELEASE ORAL 20221223 N/A ANDA ANDA209081 Aurobindo Pharma Limited RANOLAZINE 500 mg/1 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-99)
59651-009-60 59651-009 HUMAN PRESCRIPTION DRUG Ranolazine Ranolazine TABLET, FILM COATED, EXTENDED RELEASE ORAL 20221223 N/A ANDA ANDA209081 Aurobindo Pharma Limited RANOLAZINE 500 mg/1 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-60)
59651-009-18 59651-009 HUMAN PRESCRIPTION DRUG Ranolazine Ranolazine TABLET, FILM COATED, EXTENDED RELEASE ORAL 20221223 N/A ANDA ANDA209081 Aurobindo Pharma Limited RANOLAZINE 500 mg/1 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-18)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase